Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
130 pending office actions • 65 art units • 120 examiners • 0 of 130 (0%) have an AI response strategy ready • 113 patents granted in the last 365 days
THE GENERAL HOSPITAL Corporation has 127 pending office actions in the Biotechnology & Pharmaceuticals technology area. These filings are spread across 65 distinct art units. The company interacts with 117 distinct examiners to prosecute these applications. This high count of 117 distinct examiners across 65 distinct art units indicates that the company's patent work is widely distributed across the patent office's staff and technical groups.
NILOOFAR RAHMANI is the busiest examiner for this portfolio, with 2 pending actions. This represents 2 of the 127 total pending office actions. For a practitioner, this data shows that the company rarely deals with the same examiner twice. With 117 distinct examiners involved, prosecution strategies must be highly customized for each matter, as there is almost no opportunity to build a consistent rapport with any single examiner across the 127 pending office actions.
Based on the USPTO statutory response window for each pending office action. 49 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 49 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (2%) |
| §101 + other | 21 (16%) |
| §103 only | 35 (27%) |
| §102 only | 1 (1%) |
| §112 only | 5 (4%) |
| Double-patenting only | 3 (2%) |
| Double-patenting + other | 15 (12%) |
| Multi-statute (no §101) | 46 (35%) |
| No statute on record | 2 (2%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAHMANI, NILOOFAR | 2 | 77.5% | -2.9% |
| BELLAH, JEFFREY LAWRENCE | 2 | 100.0% | +0.0% |
| SHOMER, ISAAC | 2 | 63.2% | +30.4% |
| SKELDING, ZACHARY S | 2 | 59.7% | +41.2% |
| CASH, KAILEY ELIZABETH | 2 | 28.6% | +64.3% |
| LEE, YIE CHIA | 2 | 69.2% | +46.6% |
| POHNERT, STEVEN C | 2 | 12.4% | +18.5% |
| FETTEROLF, BRANDON J | 2 | 52.0% | +17.4% |
| JOHNSON, CHRISTOPHER LINDSAY | 2 | 46.9% | +81.0% |
| DENT, ALANA HARRIS | 2 | 44.2% | +32.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17996911 | SYSTEMS AND METHODS FOR ADMINISTERING A SMELL TEST FOR SARS CORONAVIRUSES AND COVID-19 | TOTH, KAREN E | 190d overdue |
| 18024179 | METHODS FOR IDENTIFYING CROSS-MODAL FEATURES FROM SPATIALLY RESOLVED DATA SETS | TRAN, DUY ANH | 132d overdue |
| 18014580 | INTERLEUKIN 33 (IL-33) INHIBITION FOR TREATMENT OF CANCER, FIBROSIS AND INFLAMMATION | HERNANDEZ, JACKSON J | 91d overdue |
| 16640942 | METHODS FOR MODULATING THE INTERACTION BETWEEN EWS-FLI1 AND BAF COMPLEXES | DENT, ALANA HARRIS | 87d overdue |
| 17636272 | SINGLE-CELL MODELING OF CLINICAL DATA TO DETERMINE RED BLOOD CELL REGULATION | VASSELL, MEREDITH ABBOTT | 85d overdue |
| 18008316 | SYSTEMS AND METHODS FOR NITRIC OXIDE GENERATION AND TREATMENT | RHEE, KELSEY | 73d overdue |
| 18818268 | ANTIBODIES WITH FC MODIFICATIONS AND METHODS OF USING THE SAME | GUSTILO, ESTELLA M | 72d overdue |
| 17923838 | Translation Blockers Repurposed for COVID-19 Therapy | ANDERSON, JAMES D | 72d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18010695 | TARGETED ABERRANT ALPHA-SYNUCLEIN SPECIES AND INDUCED UBIQUITINATION AND PROTEOSOMAL CLEARANCE VIA CO-RECRUITMENT OF AN E3-LIGASE SYSTEM | FETTEROLF, BRANDON J | 160d overdue |
| 16640942 | METHODS FOR MODULATING THE INTERACTION BETWEEN EWS-FLI1 AND BAF COMPLEXES | DENT, ALANA HARRIS | 87d overdue |
| 18021625 | PANCREATIC DUCTAL ADENOCARCINOMA SIGNATURES AND USES THEREOF | POHNERT, STEVEN C | 52d overdue |
| 18007822 | METHODS OF TREATING A CORONAVIRUS INFECTION | JOHNSON, CHRISTOPHER LINDSAY | 3d overdue |
| 17912272 | TARGETED DEGRADERS OF ABERRANT TAU BASED ON THE PET TRACER PBB3 | FETTEROLF, BRANDON J | 7d |
| 17627975 | SELF-ASSEMBLED VACCINES AND COMBINATION THERAPIES FOR TREATING CANCER | LEE, YIE CHIA | 78d |
| 18290135 | MOLECULAR PROBES FOR IN VIVO DETECTION OF ALDEHYDES | SHOMER, ISAAC | — |
| 18477532 | CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING THE TUMOR MICROENVIRONMENT | SKELDING, ZACHARY S | — |
| Art Unit | Apps |
|---|---|
| 1683 | 8 |
| 3797 | 5 |
| 3791 | 4 |
| 1645 | 4 |
| 1642 | 4 |
| 3798 | 3 |
| 3781 | 3 |
| 1613 | 3 |
| 3795 | 2 |
| 1646 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19299570 | SYSTEM AND METHOD FOR DETECTING ACUTE BRAIN FUNCTION IMPAIRMENT | FERNANDEZ, KATHERINE L | — | §102§103DP | Non-Final OA | — | Pending | Aug 14, 2025 |
| 19231352 | MINITUARIZED INTRAVASCULAR FLUORESCENCE-ULTRASOUND IMAGING CATHETER | MOHAMMED, SHAHDEEP | 3797 | §102DP | Non-Final OA | — | Pending | Jun 06, 2025 |
| 19229786 | METHODS OF MAKING THERAPEUTIC POLYMERIC MATERIAL | BOWMAN, ANDREW J | 1717 | DP | Non-Final OA | — | Pending | Jun 05, 2025 |
| 19127809 | SYSTEMS AND METHODS FOR LONG HAIR TRANSPLANTATION | HOAG, MITCHELL BRAIN | — | §103 | Non-Final OA | — | Pending | May 07, 2025 |
| 19110542 | MICROMOTOR AND OPTICAL ARRANGEMENT FOR FAST CIRCULAR SCANNING OF LIGHT BEAMS IN SMALL DIAMETER FLEXIBLE CATHETERS | FAIRCHILD, AARON BENJAMIN | 3795 | §102§103§112 | Non-Final OA | — | Pending | Mar 11, 2025 |
| 19109980 | SYSTEMS AND METHODS FOR ATTENUATING ACOUSTIC WAVES | BARBOZA, MARCUS ALEXANDER | — | §103 | Non-Final OA | — | Pending | Mar 07, 2025 |
| 18881222 | SYSTEMS FOR ELECTROENCEPHALOGRAPY AND METHODS FOR MANUFACTURE OF THE SAME | SHOULDERS, ANNIE LEE | 3794 | §102§103§112 | Non-Final OA | — | Pending | Jan 03, 2025 |
| 18988259 | SYSTEMS AND METHODS FOR STIMULATED BRILLOUIN MICROSCOPY | NGUYEN, KEMAYA DEANN HUU | — | §103 | Non-Final OA | — | Pending | Dec 19, 2024 |
| 18963054 | SYSTEM AND METHOD FOR ELECTROMAGNETIC INTERFERENCE MITIGATION FOR PORTABLE MRI SYSTEMS | CURRAN, GREGORY H | — | §103 | Non-Final OA | — | Pending | Nov 27, 2024 |
| 18870158 | NEGATIVE PRESSURE LASER HANDPIECE | BAKKAR, AYA ZIAD | — | §102§112 | Non-Final OA | — | Pending | Nov 27, 2024 |
| 18940226 | SYSTEM AND METHOD FOR EAR-ARRANGED TRANSCUTANEOUS VAGUS NERVE STIMULATION | DOWNEY, JOHN R | — | §102§103§112 | Non-Final OA | — | Pending | Nov 07, 2024 |
| 18862293 | SYSTEMS AND METHODS FOR ELECTROPHYSIOLOGICAL SIGNAL RECORDING AND POSITION OR MOTION MONITORING DURING MAGNETIC RESONANCE IMAGING | JASANI, ASHISH SHIRISH | 3798 | §102§103 | Final Rejection | 8d | Pending | Nov 01, 2024 |
| 18862300 | SYSTEM FOR AND METHOD OF PLANNING AND REAL-TIME NAVIGATION FOR TRANSCRANIAL FOCUSED ULTRASOUND STIMULATION | NGUYEN, HIEN NGOC | 3797 | §103 | Non-Final OA | 29d | Pending | Nov 01, 2024 |
| 18858643 | DEEP LEARNING BASED IMAGE RECONSTRUCTION | YANG, JIANXUN | — | §103 | Non-Final OA | — | Pending | Oct 21, 2024 |
| 18889325 | Methods and Compositions for Preserving Tissues and Organs | CLARKE, TRENT R | 1651 | §103§112 | Non-Final OA | — | Pending | Sep 18, 2024 |
| 18830080 | Complexes and Ligands | RAHMANI, NILOOFAR | — | DP | Non-Final OA | — | Pending | Sep 10, 2024 |
| 18845371 | SYSTEMS AND METHODS FOR IN VIVO CHARACTERIZATION OF TUBULAR SOFT TISSUES | NGUYEN, HUONG Q | — | §101§103§112 | Non-Final OA | — | Pending | Sep 09, 2024 |
| 18818122 | DRUG ELUTING POLYMER COMPOSED OF BIODEGRADABLE POLYMERS APPLIED TO SURFACE OF MEDICAL DEVICE | FALKOWITZ, ANNA R | — | §112DP | Non-Final OA | — | Pending | Aug 28, 2024 |
| 18818268 | ANTIBODIES WITH FC MODIFICATIONS AND METHODS OF USING THE SAME | GUSTILO, ESTELLA M | 1646 | §103§112Other | Final Rejection | 72d overdue | Pending | Aug 28, 2024 |
| 18838347 | NEURAL PROGENITOR CELL COMPOSITIONS AND METHODS OF USING THE SAME | KASAYAN, KATRIEL BARCELLANO | — | §101§103§112 | Non-Final OA | — | Pending | Aug 14, 2024 |
| 18730214 | IMMUNOMODULATORY LIPIDS AND USES THEREOF | REILLY, SOPHIA JANE | — | §101§102§103§112 | Non-Final OA | — | Pending | Jul 18, 2024 |
| 18764634 | RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci | NOAKES, SUZANNE MARIE | 1656 | DP | Final Rejection | — | Pending | Jul 05, 2024 |
| 18762951 | SMALL MOLECULE PEPTIDOMIMETIC FOR THE TREATMENT OF TAUOPATHIES | SHAMEEM, GOLAM M | — | §112 | Non-Final OA | — | Pending | Jul 03, 2024 |
| 18726745 | SYSTEMS AND METHODS FOR IRRIGATING AN ANATOMIC SPACE | STIGELL, THEODORE J | — | §102§103 | Non-Final OA | — | Pending | Jul 03, 2024 |
| 18719106 | SYSTEM AND METHOD FOR CLINICAL DISORDER ASSESSMENT | OGLES, MATTHEW ERIC | 3791 | §101§102§103§112 | Non-Final OA | — | Pending | Jun 12, 2024 |
| 18663765 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR INDUCING ANTIMICROBIAL INTRACELLULAR ACTIVITY AND FOR PREVENTING AND TREATING MICROBIAL INFECTIONS | RAHMANI, NILOOFAR | — | §102 | Non-Final OA | — | Pending | May 14, 2024 |
| 18653324 | PENTAMIDINE ANALOGS | BURKETT, DANIEL JOHN | — | §102§112 | Non-Final OA | — | Pending | May 02, 2024 |
| 18705368 | SYSTEM AND METHOD FOR INTRAOPERATIVE LIFETIME IMAGING | LI, JOHN DENNY | 3798 | §112 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18704670 | ATRAUMATIC CATHETER | WRUBLESKI, MATTHEW JAMES | 3781 | §103§112 | Final Rejection | — | Pending | Apr 25, 2024 |
| 18645005 | USE OF MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR CONTRACEPTION AND OVARIAN RESERVE PRESERVATION | BORGEEST, CHRISTINA M | 1675 | §112DPOther | Non-Final OA | — | Pending | Apr 24, 2024 |
| 18703879 | METHODS AND COMPOSITION FOR THE TREATMENT OF PRADER-WILLI SYNDROME SYMPTOMS | DEVI, SARVAMANGALA | 1645 | §102§112DP | Non-Final OA | — | Pending | Apr 23, 2024 |
| 18703198 | SYSTEMS AND METHODS FOR TRANSCATHETER SURGERY | LYNCH, ROBERT A | 3771 | §102§103 | Final Rejection | — | Pending | Apr 19, 2024 |
| 18699271 | ACCESS DEVICE | VU, QUYNH-NHU HOANG | — | §102§103§112 | Non-Final OA | — | Pending | Apr 06, 2024 |
| 18618523 | DI-CUMYL PEROXIDE CROSSLINKING OF UHMWPE | BOYLE, ROBERT C | 1764 | §103Other | Non-Final OA | 15d overdue | Pending | Mar 27, 2024 |
| 18694815 | SMALL MOLECULE INHIBITORS OF TEAD-YAP | BAUER, BRIANNA LEE | 1623 | §102§103 | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18605332 | ENZYMATIC METHODS AND COMPOSITIONS FOR POLYMERIZATION OF PHOSPHORAMIDATE AND THIOPHOSPHORAMIDATE-LINKED DNA | HUDSON, AMY ROSE | — | §102§103§112DP | Non-Final OA | — | Pending | Mar 14, 2024 |
| 18602622 | GENE THERAPY FOR TUBEROUS SCLEROSIS | VIVLEMORE, TRACY ANN | — | §102§112DP | Non-Final OA | — | Pending | Mar 12, 2024 |
| 18688518 | METHODS FOR IDENTIFYING CROSS-MODAL FEATURES FROM SPATIALLY RESOLVED DATA SETS | RIVERA-MARTINEZ, GUILLERMO M | 2677 | §112 | Final Rejection | 22d overdue | Pending | Mar 01, 2024 |
| 18444413 | INJECTABLE SLURRIES AND METHODS OF MANUFACTURING AND USING THE SAME | ROSENTHAL, ANDREW S | 1613 | §103 | Non-Final OA | 63d | Pending | Feb 16, 2024 |
| 18681031 | MINIATURIZED MAGNETIC FIELD SENSOR | PATEL, RISHI R | 2896 | §103§112 | Non-Final OA | 14d | Pending | Feb 02, 2024 |
| 18428820 | COMPOSITION FOR TREATING GOUT CONTAINING CYCLODEXTRIN-CONJUGATED POLYMER NANO-DRUG AND METHOD FOR TREATING GOUT | FUBARA, BLESSING M | 1613 | §103 | Non-Final OA | 17d overdue | Pending | Jan 31, 2024 |
| 18417527 | METHODS FOR REACTIVATING GENES ON THE INACTIVE X CHROMOSOME | WHITEMAN, BRIAN A | 1636 | §112DP | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18417024 | INJECTABLE PROLONGED-RELEASE HYDROGEL FORMULATIONS OF TOLL-LIKE RECEPTOR AGONISTS FOR INTRATUMORAL INJECTION TO INCREASE IMMUNOTHERAPY RESPONSE | ANTHOPOLOS, PETER | 1611 | §103 | Final Rejection | 46d | Pending | Jan 19, 2024 |
| 18410620 | MOLECULAR ANALYSIS OF EXTRACELLULAR VESICLES (EVs) FOR THE PREDICTION AND MONITORING OF DRUG RESISTANCE IN CANCER | BELLAH, JEFFREY LAWRENCE | 1683 | §101§103§112 | Non-Final OA | — | Pending | Jan 11, 2024 |
| 18576696 | COMPOSITIONS AND METHODS FOR DECREASING PIGMENTATION | GREENE, IVAN A | 1619 | §102§103 | Non-Final OA | — | Pending | Jan 04, 2024 |
| 18396156 | Digital Analysis of Circulating Tumor Cells in Blood Samples | GROSS, CHRISTOPHER M | 1684 | §112Other | Final Rejection | — | Pending | Dec 26, 2023 |
| 18543705 | Regeneration of a Functional Pulmonary Vascular Bed | PYLA, EVELYN Y | 1633 | §103 | Final Rejection | — | Pending | Dec 18, 2023 |
| 18571154 | METHODS TO CHARACTERIZE FUNCTIONAL AND DYSFUNCTIONAL ACUTE INFLAMMATORY RESPONSES TO PATHOLOGIC PROCESSES | HOLCOMB, MARK | 3685 | §101§103 | Final Rejection | 56d overdue | Pending | Dec 15, 2023 |
| 18516366 | PROTEIN PROSTHESES FOR MITOCHONDRIAL DISEASES OR CONDITIONS | WEHBE, ANNE MARIE SABRINA | 1634 | §112 | Final Rejection | — | Pending | Nov 21, 2023 |
| 18511416 | Virus-like Particles with Programmable Tropism and Methods of Use Thereof for Delivery to Cells | CORNELIUS, CLAIRE ADRIENNE | 1672 | §101§102§103§112DP | Non-Final OA | — | Pending | Nov 16, 2023 |
| 18507778 | Compositions and Methods for Targeting Cancer Stem Cells | COOK, LISA V | 1642 | §103§112DP | Non-Final OA | — | Pending | Nov 13, 2023 |
| 18290135 | MOLECULAR PROBES FOR IN VIVO DETECTION OF ALDEHYDES | SHOMER, ISAAC | 1612 | §102§103§112 | Non-Final OA | — | Pending | Nov 09, 2023 |
| 18289836 | Targeting Extracellular Matrix Proteins to Regulate NK Cell Function in Peripheral Tissues | PRIEST, JESSICA MARIE | 1642 | §102§112Other | Non-Final OA | — | Pending | Nov 07, 2023 |
| 18499179 | SYSTEMS AND METHODS FOR SUPERVISED REMOTE IMAGING-GUIDED INTERVENTION | POPESCU, GABRIEL VICTOR | 3797 | §103 | Final Rejection | — | Pending | Oct 31, 2023 |
| 18287948 | FLUIDIC TRANSISTORS AND USES THEREOF | HERON, VELVET ELIZABETH | 1798 | §102§103§112 | Non-Final OA | — | Pending | Oct 23, 2023 |
| 18555407 | PHOTOCHEMICAL TISSUE BONDING CLAMP AND IRRADIATION CHAMBER AND METHOD OF USE THEREOF | DIETRICH, JOSEPH M | 3796 | §102§103 | Final Rejection | 15d overdue | Pending | Oct 13, 2023 |
| 18552972 | COMPACT SIGNAL FEATURE EXTRACTION FROM MULTI-CONTRAST MAGNETIC RESONANCE IMAGES USING SUBSPACE RECONSTRUCTION | DULANEY, BENJAMIN O | 2683 | §102§103 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18477532 | CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING THE TUMOR MICROENVIRONMENT | SKELDING, ZACHARY S | 1644 | §102§103DP | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18551349 | INJECTABLE FILLER FROM AUTOLOGOUS DERMIS WITHOUT DONOR SCARRING | ALEMAN, SARAH WEBB | 3774 | §103 | Final Rejection | 8d | Pending | Sep 19, 2023 |
| 18282421 | Compositions and Methods for the Treatment of Conditions Associated with Nucleotide Repeat Expansion | REGA, KYLE THOMAS | 1636 | §102§103§112 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18468384 | PANELS AND METHODS FOR TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA | CASH, KAILEY ELIZABETH | 1683 | §101§102§103§112 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18459672 | METHODS FOR DETERMINING A NUCLEOTIDE SEQUENCE CONTIGUOUS TO A KNOWN TARGET NUCLEOTIDE SEQUENCE | BERTAGNA, ANGELA MARIE | 1681 | §112DP | Non-Final OA | — | Pending | Sep 01, 2023 |
| 18279848 | PERSONALIZED REDIRECTION AND REPROGRAMMING OF T CELLS FOR PRECISE TARGETING OF TUMORS | ALDARONDO, DASIA ALI | 1647 | §102§103§112 | Final Rejection | 33d | Pending | Aug 31, 2023 |
| 18547969 | PHOTO-ECMO APPARATUS, SYSTEMS, AND METHODS | LE, QUYNH DAO | 3781 | §103 | Non-Final OA | 26d | Pending | Aug 25, 2023 |
| 18547258 | HIGH-THROUGHPUT ASSESSMENT OF EXOGENOUS POLYNUCLEOTIDE- OR POLYPEPTIDE-MEDIATED TRANSCRIPTOME PERTURBATIONS | BELLAH, JEFFREY LAWRENCE | 1683 | §102§103§112 | Non-Final OA | — | Pending | Aug 21, 2023 |
| 18363298 | Image-seq: A New Technology for Spatially-Resolved Single-Cell RNA Sequencing | GOMES, SRISTI DIVINA | 1683 | §101§103 | Non-Final OA | — | Pending | Aug 01, 2023 |
| 18263384 | SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES | ROMERO, KRISTEN WANG | 1624 | — | Non-Final OA | — | Pending | Jul 28, 2023 |
| 18274677 | Astrocyte Interleukin-3 Reprograms Microglia and Limits Alzheimer`s Disease | DONOGHUE, BRITTNEY ERIN | 1675 | §102§103§112 | Non-Final OA | — | Pending | Jul 27, 2023 |
| 18274641 | FC-ENHANCED ANTIBODIES FOR PREVENTION AND TREATMENT OF EBOLA VIRUS INFECTION | ALLEN, MICHAEL D | 1671 | §103§112 | Non-Final OA | 42d | Pending | Jul 27, 2023 |
| 18274435 | Methods for Treating Autism Spectrum Disorder | EDUN, DEAN NAWAAB | 3797 | §103§112 | Final Rejection | — | Pending | Jul 26, 2023 |
| 18273922 | METHODS AND COMPOSITIONS FOR INCREASING THE CONCENTRATION OF CELL FREE DNA | SHOMER, ISAAC | 1612 | §101§103§112 | Final Rejection | — | Pending | Jul 24, 2023 |
| 18273466 | T CELL-DIRECTED ANTI-CANCER VACCINES AGAINST COMMENSAL VIRUSES FOR TREATING MUCOSAL CARCINOMAS | JADHAO, SAMADHAN JAISING | 1672 | §102§103§112DP | Non-Final OA | — | Pending | Jul 20, 2023 |
| 18273395 | ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY ANTIBODIES | LEE, YIE CHIA | 1642 | §102§103§112Other | Non-Final OA | — | Pending | Jul 20, 2023 |
| 18270611 | METHODS AND COMPOSITION FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER | ZEMAN, ROBERT A | 1645 | §103 | Final Rejection | — | Pending | Jun 30, 2023 |
| 18035888 | High Throughput Microfluidics for Analysis of Immune Cell Activation | SALMON, KATHERINE D | 1682 | §103§112 | Non-Final OA | — | Pending | May 08, 2023 |
| 18312354 | SYSTEM AND METHOD FOR A MAGNETIC RESONANCE IMAGING TECHNIQUE TO IMAGING TISSUE HETEROGENEITY | DICKERSON, CHAD S | 2683 | §103 | Non-Final OA | — | Pending | May 04, 2023 |
| 18251878 | BLOOD TRANSFER SHIELD AND METHODS OF USE | NGO, MEAGAN N | 3781 | §103 | Non-Final OA | 1d overdue | Pending | May 04, 2023 |
| 18142129 | GLYCOENGINEERING | SKELDING, ZACHARY S | 1644 | §101§103DP | Non-Final OA | — | Pending | May 02, 2023 |
| 18030876 | PEPTIDE INHIBITORS OF GLIOMA-ASSOCIATED ONCOGENE DERIVED FROM THE COILED-COIL DIMERIZATION DOMAIN OF Kif7 | REYNOLDS, FRED H | 1658 | §101§112 | Non-Final OA | — | Pending | Apr 07, 2023 |
| 18030427 | INTRATUMORAL AND SYSTEMIC IMMUNIZATION USING FRACTIONAL DAMAGE-CREATING DEVICE WITH CHECKPOINT MOLECULES FOR CANCER THERAPY | PRICE, NATHAN R | 3783 | §103§112 | Non-Final OA | 27d | Pending | Apr 05, 2023 |
| 18127884 | SYSTEMS AND METHODS FOR NONCONTACT ULTRASOUND IMAGING | COOK, CHRISTOPHER L | 3797 | §103§112 | Final Rejection | — | Pending | Mar 29, 2023 |
| 18028379 | METHODS FOR EVALUATING MIS-C ASSOCIATED WITH COVID-19 | RAMIREZ, ALEX | 1798 | §101§102§103 | Final Rejection | 4d overdue | Pending | Mar 24, 2023 |
| 18025475 | AUTOMATED ANEUPLOIDY SCREENING USING ARBITRATED ENSEMBLES | YANG, WEI WEN | 2662 | §103 | Final Rejection | — | Pending | Mar 09, 2023 |
| 18024179 | METHODS FOR IDENTIFYING CROSS-MODAL FEATURES FROM SPATIALLY RESOLVED DATA SETS | TRAN, DUY ANH | 2674 | §101§102§103Other | Non-Final OA | 132d overdue | Pending | Mar 01, 2023 |
| 18024182 | COMPOSITIONS AND METHODS FOR TREATING THERAPY RESISTANT CANCER | SHIN, DANA H | 1635 | §102§103 | Non-Final OA | — | Pending | Mar 01, 2023 |
| 18021625 | PANCREATIC DUCTAL ADENOCARCINOMA SIGNATURES AND USES THEREOF | POHNERT, STEVEN C | 1683 | §101§112 | Final Rejection | 52d overdue | Pending | Feb 16, 2023 |
| 18169695 | HEMOSTATIC NANOPARTICLES FOR THE TREATMENT OF NON-COMPRESSIBLE HEMORRHAGE AND INTERNAL BLEEDING | STEVENS, MARK V | 1613 | §103§112 | Final Rejection | 14d | Pending | Feb 15, 2023 |
| 18014580 | INTERLEUKIN 33 (IL-33) INHIBITION FOR TREATMENT OF CANCER, FIBROSIS AND INFLAMMATION | HERNANDEZ, JACKSON J | 1627 | §102§103 | Non-Final OA | 91d overdue | Pending | Jan 05, 2023 |
| 18149520 | METHODS AND COMPOSITIONS FOR REDUCING IMMUNOSUPPRESSION BY TUMOR CELLS | GIBBS, TERRA C | 1635 | §101 | Non-Final OA | — | Pending | Jan 03, 2023 |
| 18010695 | TARGETED ABERRANT ALPHA-SYNUCLEIN SPECIES AND INDUCED UBIQUITINATION AND PROTEOSOMAL CLEARANCE VIA CO-RECRUITMENT OF AN E3-LIGASE SYSTEM | FETTEROLF, BRANDON J | 1626 | §103 | Non-Final OA | 160d overdue | Pending | Dec 15, 2022 |
| 18008316 | SYSTEMS AND METHODS FOR NITRIC OXIDE GENERATION AND TREATMENT | RHEE, KELSEY | 3785 | §102§103 | Final Rejection | 73d overdue | Pending | Dec 05, 2022 |
| 18007822 | METHODS OF TREATING A CORONAVIRUS INFECTION | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §103 | Non-Final OA | 3d overdue | Pending | Dec 02, 2022 |
| 18000222 | SINGLE CELL COMBINATORIAL INDEXING FROM AMPLIFIED NUCLEIC ACIDS | CASH, KAILEY ELIZABETH | 1683 | §103 | Final Rejection | — | Pending | Nov 29, 2022 |
| 17923838 | Translation Blockers Repurposed for COVID-19 Therapy | ANDERSON, JAMES D | 1629 | §102§112 | Non-Final OA | 72d overdue | Pending | Nov 07, 2022 |
| 17972772 | CROMOLYN COMPOSITIONS AND METHODS THEREOF | SASAN, ARADHANA | 1615 | §103 | Non-Final OA | — | Pending | Oct 25, 2022 |
| 17996911 | SYSTEMS AND METHODS FOR ADMINISTERING A SMELL TEST FOR SARS CORONAVIRUSES AND COVID-19 | TOTH, KAREN E | 3791 | §101§102§103§112 | Non-Final OA | 190d overdue | Pending | Oct 21, 2022 |
| 17919848 | Fluorinated Derivatives of Gabapentin and Methods of Use Thereof | DONOHUE, SEAN R | 1618 | §103 | Non-Final OA | 29d overdue | Pending | Oct 19, 2022 |
| 18046327 | TAU MODULATORS AND METHODS AND COMPOSITIONS FOR DELIVERY THEREOF | NGUYEN, QUANG | 1631 | §102§103§112 | Non-Final OA | — | Pending | Oct 13, 2022 |
| 17937025 | Artifact Removal from Electrodermal Activity Data | BAIG, RUMAISA RASHID | 3796 | §101§103 | Final Rejection | — | Pending | Sep 30, 2022 |
| 17912272 | TARGETED DEGRADERS OF ABERRANT TAU BASED ON THE PET TRACER PBB3 | FETTEROLF, BRANDON J | 1626 | §103 | Final Rejection | 7d | Pending | Sep 16, 2022 |
| 17908810 | METHODS AND SYSTEMS TO PRINT AND MATURE TISSUES OVER TIME IN A THREE-DIMENSIONAL SUPPORT MATRIX | NGUYEN, NGHI V | 1653 | §103 | Non-Final OA | 80d overdue | Pending | Sep 01, 2022 |
| 17791770 | STIMULATION OF HAIR GROWTH | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §103 | Non-Final OA | — | Pending | Jul 08, 2022 |
| 17784935 | ENGINEERED IMMUNE CELLS WITH REDUCED TOXICITY AND USES THEREOF | WESTON, ALYSSA G | 1633 | §102§103§112 | Final Rejection | 16d overdue | Pending | Jun 13, 2022 |
| 17781279 | Nerve Xenografts and Related Methods | BARRON, SEAN C | 1653 | §103 | Non-Final OA | — | Pending | May 31, 2022 |
| 17767140 | COMPOSITIONS AND METHODS FOR PULMONARY SURFACTANT-BIOMIMETIC NANOPARTICLES | HAGOPIAN, CASEY SHEA | 1617 | §102§112 | Non-Final OA | — | Pending | Apr 07, 2022 |
| 17689117 | METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY | ABBAS, SYED JARAR | 1645 | §102§112 | Non-Final OA | 14d | Pending | Mar 08, 2022 |
| 17636272 | SINGLE-CELL MODELING OF CLINICAL DATA TO DETERMINE RED BLOOD CELL REGULATION | VASSELL, MEREDITH ABBOTT | 1687 | §101§103 | Final Rejection | 85d overdue | Pending | Feb 17, 2022 |
| 17673741 | OPTICAL COUPLER FOR AN ENDOSCOPE | LUU, TIMOTHY TUAN | 3795 | §103 | Final Rejection | 15d overdue | Pending | Feb 16, 2022 |
| 17669904 | DIAGNOSIS AND TREATMENT OF CARDIOMYOPATHY | ZHU, JIANJIAN | 1631 | §101§103 | Non-Final OA | — | Pending | Feb 11, 2022 |
| 17627975 | SELF-ASSEMBLED VACCINES AND COMBINATION THERAPIES FOR TREATING CANCER | LEE, YIE CHIA | 1642 | §103§112Other | Final Rejection | 78d | Pending | Jan 18, 2022 |
| 17626728 | ZEBRAFISH DELETION AND COMPOUND MUTANTS AND USES THEREOF | BEHARRY, ZANNA MARIA | 1632 | §101§103§112 | Non-Final OA | 9d overdue | Pending | Jan 12, 2022 |
| 17553999 | SYSTEMS AND METHODS FOR PERFUSING A HUMAN PLACENTA-BASED MRI PHANTOM | BURKE, TIONNA M | 2178 | §103 | Non-Final OA | 31d overdue | Pending | Dec 17, 2021 |
| 17619958 | IMMUNE CELL SIGNATURE FOR BACTERIAL SEPSIS | IVICH, FERNANDO NMN | 1678 | — | Non-Final OA | 81d overdue | Pending | Dec 16, 2021 |
| 17609137 | MONITORING AND ALTERING THE GUT MICROBIOME IN DISEASE | EDWARDS, JESSICA FAYE | 1657 | §103 | Non-Final OA | — | Pending | Nov 05, 2021 |
| 17513640 | PREDICTING BREAST CANCER RECURRENCE | POHNERT, STEVEN C | 1683 | §103§112DP | Non-Final OA | — | Pending | Oct 28, 2021 |
| 17602076 | Enhancement of Melanocyte Migration Using ROCK Inhibitors | MCKILLOP, JOHN CHARLES | 1637 | §103§112 | Final Rejection | 2d overdue | Pending | Oct 07, 2021 |
| 17434349 | TREATMENT OF BENIGN NERVOUS SYSTEM TUMORS USING ATTENUATED SALMONELLA TYPHIMURIUM | OGUNBIYI, OLUWATOSIN A | 1645 | §103 | Final Rejection | 50d overdue | Pending | Aug 26, 2021 |
| 17330316 | SYSTEMS AND METHODS FOR EPIGENETIC SEQUENCING | CHUNDURU, SURYAPRABHA | 1683 | §112DP | Final Rejection | — | Pending | May 25, 2021 |
| 17296829 | T Cell-Directed Anti-Cancer Vaccines Against Commensal Viruses | SIFFORD, JEFFREY MARK | 1671 | §103§112Other | Non-Final OA | 61d | Pending | May 25, 2021 |
| 17291588 | METHODS FOR CONSOLIDATING ANTIBIOTIC-ELUTING POLYMERIC MATERIALS | GALSTER, SAMUEL LEONARD | 1693 | §103DP | Non-Final OA | 76d | Pending | May 05, 2021 |
| 17287349 | MULTIPLEXED SINGLE-CELL ANALYSIS USING OPTICALLY-ENCODED RNA CAPTURE PARTICLES | ESPERON, NATHAN GREGORY | 1799 | §103 | Non-Final OA | 12d | Pending | Apr 21, 2021 |
| 17270393 | MULTIFUNCTIONAL SKIN PATCH | MULLINS, JESSICA LYNN | 3792 | §103 | Non-Final OA | 43d overdue | Pending | Feb 22, 2021 |
| 17257391 | ANTIBODY TUMOR-TARGETING ASSEMBLY COMPLEXES | BRISTOL, LYNN ANNE | 1600 | §103§112Other | Non-Final OA | — | Pending | Dec 31, 2020 |
| 17101028 | METHODS AND ASSAYS RELATING TO CIRCULATING TUMOR CELLS | DENT, ALANA HARRIS | 1643 | §103 | Final Rejection | — | Pending | Nov 23, 2020 |
| 16944588 | SYSTEMS AND METHODS THAT FACILITATE TATTOO REMOVAL | PATEL, SHEFALI DILIP | 3783 | §103 | Non-Final OA | 72d overdue | Pending | Jul 31, 2020 |
| 16802841 | Systems and Methods For Improved Brain Monitoring During General Anesthesia And Sedation | AGAHI, PUYA | 3791 | §101 | Non-Final OA | — | Pending | Feb 27, 2020 |
| 16640942 | METHODS FOR MODULATING THE INTERACTION BETWEEN EWS-FLI1 AND BAF COMPLEXES | DENT, ALANA HARRIS | 1643 | §103§112 | Final Rejection | 87d overdue | Pending | Feb 21, 2020 |
| 16349405 | SYSTEMS AND METHODS FOR MULTI-DISTANCE, MULTI-WAVELENGTH DIFFUSE CORRELATION SPECTROSCOPY | VIRK, ADIL PARTAP S | 3798 | §103§112 | Non-Final OA | 10d overdue | Pending | May 13, 2019 |
| 16293325 | SYSTEM AND METHOD FOR MONITORING AND CONTROLLING A STATE OF A PATIENT DURING AND AFTER ADMINISTRATION OF ANESTHETIC COMPOUND | BERHANU, ETSUB D | 3791 | §101§103§112 | Final Rejection | 51d overdue | Pending | Mar 05, 2019 |
| 16094786 | IMPROVED HLA EPITOPE PREDICTION | HALVORSON, MARK | 1646 | §103§112 | Final Rejection | 4d overdue | Pending | Oct 18, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial